APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Dog Prescription Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Dog Prescription Drugs Industry Growth and Trends Forecast to 2032

Report ID 173985510122 December 2025108 pages

Choose your research edition.

Industry ResearchDog Prescription Drugs Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Dog Prescription Drugs Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Dog Prescription Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dog Prescription Drugs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Dog Prescription Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Dog Prescription Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Dog Prescription Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Dog Prescription Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dog Prescription Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dog Prescription Drugs include Zoetis, Virbac, Vetoquinol, Ourofino Saude Animal, MSD Animal Health, Elanco Animal Health, Dechra, Ceva Sante Animale and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Dog Prescription Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Dog Prescription Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dog Prescription Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dog Prescription Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Dog Prescription Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Dog Prescription Drugs Market by Company

Zoetis

Virbac

Vetoquinol

Ourofino Saude Animal

MSD Animal Health

Elanco Animal Health

Dechra

Ceva Sante Animale

Boehringer Ingelheim

Animalcare Group

Dog Prescription Drugs Segment by Type

Oral Type

Spray Type

Smear Type

Injection Type

Dog Prescription Drugs Segment by Application

Hospital

Clinic

Others

Dog Prescription Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dog Prescription Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dog Prescription Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dog Prescription Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dog Prescription Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Dog Prescription Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Type Table 2. Major Company of Spray Type Table 3. Major Company of Smear Type Table 4. Major Company of Injection Type Table 5. Global Dog Prescription Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Dog Prescription Drugs Sales by Type (2021-2026) & (k units) Table 7. Global Dog Prescription Drugs Sales Market Share in Volume by Type (2021-2026) Table 8. Global Dog Prescription Drugs Sales by Type (2021-2026) & (US$ Million) Table 9. Global Dog Prescription Drugs Sales Market Share in Value by Type (2021-2026) Table 10. Global Dog Prescription Drugs Price by Type (2021-2026) & (US$/unit) Table 11. Global Dog Prescription Drugs Sales by Type (2027-2032) & (k units) Table 12. Global Dog Prescription Drugs Sales Market Share in Volume by Type (2027-2032) Table 13. Global Dog Prescription Drugs Sales by Type (2027-2032) & (US$ Million) Table 14. Global Dog Prescription Drugs Sales Market Share in Value by Type (2027-2032) Table 15. Global Dog Prescription Drugs Price by Type (2027-2032) & (US$/unit) Table 16. North America Dog Prescription Drugs Sales by Type (2021-2026) & (k units) Table 17. North America Dog Prescription Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Dog Prescription Drugs Sales by Type (2021-2026) & (k units) Table 19. Europe Dog Prescription Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Dog Prescription Drugs Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Dog Prescription Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Dog Prescription Drugs Sales by Type (2021-2026) & (k units) Table 23. Latin America Dog Prescription Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Dog Prescription Drugs Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Dog Prescription Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Dog Prescription Drugs Industry Trends Table 27. Dog Prescription Drugs Industry Drivers Table 28. Dog Prescription Drugs Industry Opportunities and Challenges Table 29. Dog Prescription Drugs Industry Restraints Table 30. Global Dog Prescription Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Dog Prescription Drugs Revenue Market Share by Company (2021-2026) Table 32. Global Dog Prescription Drugs Sales by Company (2021-2026) & (k units) Table 33. Global Dog Prescription Drugs Sales Share by Company (2021-2026) Table 34. Global Dog Prescription Drugs Market Price by Company (2021-2026) & (US$/unit) Table 35. Global Dog Prescription Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Dog Prescription Drugs Major Company Production Sites and Headquarters Table 37. Global Dog Prescription Drugs Company, Product Type & Application Table 38. Global Dog Prescription Drugs Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Dog Prescription Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Dog Prescription Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Dog Prescription Drugs Sales by Region (2021-2026) & (k units) Table 43. Global Dog Prescription Drugs Sales Market Share in Volume by Region (2021-2026) Table 44. Global Dog Prescription Drugs Sales by Region (2021-2026) & (US$ Million) Table 45. Global Dog Prescription Drugs Sales Market Share in Value by Region (2021-2026) Table 46. Global Dog Prescription Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 47. Global Dog Prescription Drugs Sales by Region (2027-2032) & (k units) Table 48. Global Dog Prescription Drugs Sales Market Share in Volume by Region (2027-2032) Table 49. Global Dog Prescription Drugs Sales by Region (2027-2032) & (US$ Million) Table 50. Global Dog Prescription Drugs Sales Market Share in Value by Region (2027-2032) Table 51. Global Dog Prescription Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 52. Global Dog Prescription Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Dog Prescription Drugs Sales by Application (2021-2026) & (k units) Table 54. Global Dog Prescription Drugs Sales Market Share in Volume by Application (2021-2026) Table 55. Global Dog Prescription Drugs Sales by Application (2021-2026) & (US$ Million) Table 56. Global Dog Prescription Drugs Sales Market Share in Value by Application (2021-2026) Table 57. Global Dog Prescription Drugs Price by Application (2021-2026) & (US$/unit) Table 58. Global Dog Prescription Drugs Sales by Application (2027-2032) & (k units) Table 59. Global Dog Prescription Drugs Sales Market Share in Volume by Application (2027-2032) Table 60. Global Dog Prescription Drugs Sales by Application (2027-2032) & (US$ Million) Table 61. Global Dog Prescription Drugs Sales Market Share in Value by Application (2027-2032) Table 62. Global Dog Prescription Drugs Price by Application (2027-2032) & (US$/unit) Table 63. North America Dog Prescription Drugs Sales by Application (2021-2026) & (k units) Table 64. North America Dog Prescription Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Dog Prescription Drugs Sales by Application (2021-2026) & (k units) Table 66. Europe Dog Prescription Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Dog Prescription Drugs Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Dog Prescription Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Dog Prescription Drugs Sales by Application (2021-2026) & (k units) Table 70. Latin America Dog Prescription Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Dog Prescription Drugs Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Dog Prescription Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Zoetis Company Information Table 74. Zoetis Business Overview Table 75. Zoetis Dog Prescription Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Zoetis Dog Prescription Drugs Product Portfolio Table 77. Zoetis Recent Development Table 78. Virbac Company Information Table 79. Virbac Business Overview Table 80. Virbac Dog Prescription Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Virbac Dog Prescription Drugs Product Portfolio Table 82. Virbac Recent Development Table 83. Vetoquinol Company Information Table 84. Vetoquinol Business Overview Table 85. Vetoquinol Dog Prescription Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Vetoquinol Dog Prescription Drugs Product Portfolio Table 87. Vetoquinol Recent Development Table 88. Ourofino Saude Animal Company Information Table 89. Ourofino Saude Animal Business Overview Table 90. Ourofino Saude Animal Dog Prescription Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Ourofino Saude Animal Dog Prescription Drugs Product Portfolio Table 92. Ourofino Saude Animal Recent Development Table 93. MSD Animal Health Company Information Table 94. MSD Animal Health Business Overview Table 95. MSD Animal Health Dog Prescription Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. MSD Animal Health Dog Prescription Drugs Product Portfolio Table 97. MSD Animal Health Recent Development Table 98. Elanco Animal Health Company Information Table 99. Elanco Animal Health Business Overview Table 100. Elanco Animal Health Dog Prescription Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Elanco Animal Health Dog Prescription Drugs Product Portfolio Table 102. Elanco Animal Health Recent Development Table 103. Dechra Company Information Table 104. Dechra Business Overview Table 105. Dechra Dog Prescription Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Dechra Dog Prescription Drugs Product Portfolio Table 107. Dechra Recent Development Table 108. Ceva Sante Animale Company Information Table 109. Ceva Sante Animale Business Overview Table 110. Ceva Sante Animale Dog Prescription Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Ceva Sante Animale Dog Prescription Drugs Product Portfolio Table 112. Ceva Sante Animale Recent Development Table 113. Boehringer Ingelheim Company Information Table 114. Boehringer Ingelheim Business Overview Table 115. Boehringer Ingelheim Dog Prescription Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Boehringer Ingelheim Dog Prescription Drugs Product Portfolio Table 117. Boehringer Ingelheim Recent Development Table 118. Animalcare Group Company Information Table 119. Animalcare Group Business Overview Table 120. Animalcare Group Dog Prescription Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Animalcare Group Dog Prescription Drugs Product Portfolio Table 122. Animalcare Group Recent Development Table 123. North America Dog Prescription Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 124. North America Dog Prescription Drugs Sales by Country (2021-2026) & (k units) Table 125. North America Dog Prescription Drugs Sales Market Share by Country (2021-2026) Table 126. North America Dog Prescription Drugs Sales Forecast by Country (2027-2032) & (k units) Table 127. North America Dog Prescription Drugs Sales Market Share Forecast by Country (2027-2032) Table 128. North America Dog Prescription Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Dog Prescription Drugs Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Dog Prescription Drugs Market Share by Country (2021-2026) Table 131. North America Dog Prescription Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Dog Prescription Drugs Market Share Forecast by Country (2027-2032) Table 133. Europe Dog Prescription Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 134. Europe Dog Prescription Drugs Sales by Country (2021-2026) & (k units) Table 135. Europe Dog Prescription Drugs Sales Market Share by Country (2021-2026) Table 136. Europe Dog Prescription Drugs Sales Forecast by Country (2027-2032) & (k units) Table 137. Europe Dog Prescription Drugs Sales Market Share Forecast by Country (2027-2032) Table 138. Europe Dog Prescription Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Dog Prescription Drugs Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Dog Prescription Drugs Market Share by Country (2021-2026) Table 141. Europe Dog Prescription Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Dog Prescription Drugs Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Dog Prescription Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Dog Prescription Drugs Sales by Country (2021-2026) & (k units) Table 145. Asia-Pacific Dog Prescription Drugs Sales Market Share by Country (2021-2026) Table 146. Asia-Pacific Dog Prescription Drugs Sales Forecast by Country (2027-2032) & (k units) Table 147. Asia-Pacific Dog Prescription Drugs Sales Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Dog Prescription Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Dog Prescription Drugs Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Dog Prescription Drugs Market Share by Country (2021-2026) Table 151. Asia-Pacific Dog Prescription Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Dog Prescription Drugs Market Share Forecast by Country (2027-2032) Table 153. Latin America Dog Prescription Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 154. Latin America Dog Prescription Drugs Sales by Country (2021-2026) & (k units) Table 155. Latin America Dog Prescription Drugs Sales Market Share by Country (2021-2026) Table 156. Latin America Dog Prescription Drugs Sales Forecast by Country (2027-2032) & (k units) Table 157. Latin America Dog Prescription Drugs Sales Market Share Forecast by Country (2027-2032) Table 158. Latin America Dog Prescription Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Latin America Dog Prescription Drugs Market Size by Country (2021-2026) & (US$ Million) Table 160. Latin America Dog Prescription Drugs Market Share by Country (2021-2026) Table 161. Latin America Dog Prescription Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Latin America Dog Prescription Drugs Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Dog Prescription Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Dog Prescription Drugs Sales by Country (2021-2026) & (k units) Table 165. Middle East and Africa Dog Prescription Drugs Sales Market Share by Country (2021-2026) Table 166. Middle East and Africa Dog Prescription Drugs Sales Forecast by Country (2027-2032) & (k units) Table 167. Middle East and Africa Dog Prescription Drugs Sales Market Share Forecast by Country (2027-2032) Table 168. Middle East and Africa Dog Prescription Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East and Africa Dog Prescription Drugs Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East and Africa Dog Prescription Drugs Market Share by Country (2021-2026) Table 171. Middle East and Africa Dog Prescription Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East and Africa Dog Prescription Drugs Market Share Forecast by Country (2027-2032) Table 173. Key Raw Materials Table 174. Raw Materials Key Suppliers Table 175. Dog Prescription Drugs Distributors List Table 176. Dog Prescription Drugs Customers List Table 177. Research Programs/Design for This Report Table 178. Authors List of This Report Table 179. Secondary Sources Table 180. Primary Sources List of Figures Figure 1. Dog Prescription Drugs Image Figure 2. Global Dog Prescription Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dog Prescription Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Dog Prescription Drugs Sales (2021-2032) & (k units) Figure 5. Oral Type Image Figure 6. Global Oral Type Sales YoY Growth (2021-2032) & (k units) Figure 7. Spray Type Image Figure 8. Global Spray Type Sales YoY Growth (2021-2032) & (k units) Figure 9. Smear Type Image Figure 10. Global Smear Type Sales YoY Growth (2021-2032) & (k units) Figure 11. Injection Type Image Figure 12. Global Injection Type Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Dog Prescription Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Dog Prescription Drugs Market Share by Type 2025 VS 2032 Figure 15. North America Dog Prescription Drugs Sales Market Share in Volume by Type in 2025 Figure 16. North America Dog Prescription Drugs Sales Market Share in Value by Type in 2025 Figure 17. Europe Dog Prescription Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Europe Dog Prescription Drugs Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Dog Prescription Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Dog Prescription Drugs Sales Market Share in Value by Type in 2025 Figure 21. Latin America Dog Prescription Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Dog Prescription Drugs Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Dog Prescription Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Dog Prescription Drugs Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Dog Prescription Drugs Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Dog Prescription Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Dog Prescription Drugs Market Share by Application 2025 VS 2032 Figure 35. North America Dog Prescription Drugs Sales Market Share in Volume by Application in 2025 Figure 36. North America Dog Prescription Drugs Sales Market Share in Value by Application in 2025 Figure 37. Europe Dog Prescription Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Europe Dog Prescription Drugs Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Dog Prescription Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Dog Prescription Drugs Sales Market Share in Value by Application in 2025 Figure 41. Latin America Dog Prescription Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Dog Prescription Drugs Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Dog Prescription Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Dog Prescription Drugs Sales Market Share in Value by Application in 2025 Figure 45. North America Dog Prescription Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Dog Prescription Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Dog Prescription Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Dog Prescription Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Dog Prescription Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Dog Prescription Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Dog Prescription Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Dog Prescription Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Dog Prescription Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Dog Prescription Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Dog Prescription Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Dog Prescription Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Dog Prescription Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Dog Prescription Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Dog Prescription Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Dog Prescription Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Dog Prescription Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Dog Prescription Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Dog Prescription Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Dog Prescription Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Dog Prescription Drugs Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Dog Prescription Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Type
  • Spray Type
  • Smear Type
  • Injection Type
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Zoetis
  • Virbac
  • Vetoquinol
  • Ourofino Saude Animal
  • MSD Animal Health
  • Elanco Animal Health
  • Dechra
  • Ceva Sante Animale
  • Boehringer Ingelheim
  • Animalcare Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dog Prescription Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Dog Prescription Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Dog Prescription Drugs Market by Type
  6. 1.3.1 Oral Type
  7. 1.3.2 Spray Type
  8. 1.3.3 Smear Type
  9. 1.3.4 Injection Type
  10. 1.4 Global Dog Prescription Drugs Market Size by Type
  11. 1.4.1 Global Dog Prescription Drugs Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Dog Prescription Drugs Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Dog Prescription Drugs Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Dog Prescription Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Dog Prescription Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Dog Prescription Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Dog Prescription Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Dog Prescription Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Dog Prescription Drugs Industry Trends
  2. 2.2 Dog Prescription Drugs Industry Drivers
  3. 2.3 Dog Prescription Drugs Industry Opportunities and Challenges
  4. 2.4 Dog Prescription Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Dog Prescription Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Dog Prescription Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Dog Prescription Drugs Price (2021-2026)
  4. 3.4 Global Dog Prescription Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dog Prescription Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Dog Prescription Drugs Company, Product Type & Application
  7. 3.7 Global Dog Prescription Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dog Prescription Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dog Prescription Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dog Prescription Drugs Tier 1, Tier 2, and Tier 3
4 Dog Prescription Drugs Regional Status and Outlook
  1. 4.1 Global Dog Prescription Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Dog Prescription Drugs Historic Market Size by Region
  3. 4.2.1 Global Dog Prescription Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Dog Prescription Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Dog Prescription Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Dog Prescription Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Dog Prescription Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Dog Prescription Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Dog Prescription Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Dog Prescription Drugs by Application
  1. 5.1 Dog Prescription Drugs Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Dog Prescription Drugs Market Size by Application
  6. 5.2.1 Global Dog Prescription Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Dog Prescription Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Dog Prescription Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Dog Prescription Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Dog Prescription Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Dog Prescription Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Dog Prescription Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Dog Prescription Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zoetis
  2. 6.1.1 Zoetis Company Information
  3. 6.1.2 Zoetis Business Overview
  4. 6.1.3 Zoetis Dog Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zoetis Dog Prescription Drugs Product Portfolio
  6. 6.1.5 Zoetis Recent Developments
  7. 6.2 Virbac
  8. 6.2.1 Virbac Company Information
  9. 6.2.2 Virbac Business Overview
  10. 6.2.3 Virbac Dog Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Virbac Dog Prescription Drugs Product Portfolio
  12. 6.2.5 Virbac Recent Developments
  13. 6.3 Vetoquinol
  14. 6.3.1 Vetoquinol Company Information
  15. 6.3.2 Vetoquinol Business Overview
  16. 6.3.3 Vetoquinol Dog Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Vetoquinol Dog Prescription Drugs Product Portfolio
  18. 6.3.5 Vetoquinol Recent Developments
  19. 6.4 Ourofino Saude Animal
  20. 6.4.1 Ourofino Saude Animal Company Information
  21. 6.4.2 Ourofino Saude Animal Business Overview
  22. 6.4.3 Ourofino Saude Animal Dog Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Ourofino Saude Animal Dog Prescription Drugs Product Portfolio
  24. 6.4.5 Ourofino Saude Animal Recent Developments
  25. 6.5 MSD Animal Health
  26. 6.5.1 MSD Animal Health Company Information
  27. 6.5.2 MSD Animal Health Business Overview
  28. 6.5.3 MSD Animal Health Dog Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 MSD Animal Health Dog Prescription Drugs Product Portfolio
  30. 6.5.5 MSD Animal Health Recent Developments
  31. 6.6 Elanco Animal Health
  32. 6.6.1 Elanco Animal Health Company Information
  33. 6.6.2 Elanco Animal Health Business Overview
  34. 6.6.3 Elanco Animal Health Dog Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Elanco Animal Health Dog Prescription Drugs Product Portfolio
  36. 6.6.5 Elanco Animal Health Recent Developments
  37. 6.7 Dechra
  38. 6.7.1 Dechra Company Information
  39. 6.7.2 Dechra Business Overview
  40. 6.7.3 Dechra Dog Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Dechra Dog Prescription Drugs Product Portfolio
  42. 6.7.5 Dechra Recent Developments
  43. 6.8 Ceva Sante Animale
  44. 6.8.1 Ceva Sante Animale Company Information
  45. 6.8.2 Ceva Sante Animale Business Overview
  46. 6.8.3 Ceva Sante Animale Dog Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Ceva Sante Animale Dog Prescription Drugs Product Portfolio
  48. 6.8.5 Ceva Sante Animale Recent Developments
  49. 6.9 Boehringer Ingelheim
  50. 6.9.1 Boehringer Ingelheim Company Information
  51. 6.9.2 Boehringer Ingelheim Business Overview
  52. 6.9.3 Boehringer Ingelheim Dog Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Boehringer Ingelheim Dog Prescription Drugs Product Portfolio
  54. 6.9.5 Boehringer Ingelheim Recent Developments
  55. 6.10 Animalcare Group
  56. 6.10.1 Animalcare Group Company Information
  57. 6.10.2 Animalcare Group Business Overview
  58. 6.10.3 Animalcare Group Dog Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Animalcare Group Dog Prescription Drugs Product Portfolio
  60. 6.10.5 Animalcare Group Recent Developments
7 North America by Country
  1. 7.1 North America Dog Prescription Drugs Sales by Country
  2. 7.1.1 North America Dog Prescription Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Dog Prescription Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Dog Prescription Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Dog Prescription Drugs Market Size by Country
  6. 7.2.1 North America Dog Prescription Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Dog Prescription Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Dog Prescription Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Dog Prescription Drugs Sales by Country
  2. 8.1.1 Europe Dog Prescription Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Dog Prescription Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Dog Prescription Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Dog Prescription Drugs Market Size by Country
  6. 8.2.1 Europe Dog Prescription Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Dog Prescription Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Dog Prescription Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Dog Prescription Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Dog Prescription Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Dog Prescription Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Dog Prescription Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Dog Prescription Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Dog Prescription Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Dog Prescription Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Dog Prescription Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Dog Prescription Drugs Sales by Country
  2. 10.1.1 South America Dog Prescription Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Dog Prescription Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Dog Prescription Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Dog Prescription Drugs Market Size by Country
  6. 10.2.1 South America Dog Prescription Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Dog Prescription Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Dog Prescription Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Dog Prescription Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Dog Prescription Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Dog Prescription Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Dog Prescription Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Dog Prescription Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Dog Prescription Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Dog Prescription Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Dog Prescription Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Dog Prescription Drugs Value Chain Analysis
  2. 12.1.1 Dog Prescription Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Dog Prescription Drugs Production Mode & Process
  7. 12.2 Dog Prescription Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Dog Prescription Drugs Distributors
  10. 12.2.3 Dog Prescription Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst